investing

Midwest Fund Mairs & Power Growth Hangs Tough

Mairs & Power Growth favors firms that are headquartered in the upper Midwest, on the theory that proximity gives them an edge.

When the market gets ugly, Mairs & Power Growth (symbol MPGFX, $124) shines. Over the occasionally odious past 12 months (including late 2018 and the recent spring swoon), the fund, a member of the Kiplinger 25, returned 8.8%, beating the 5.9% gain in Standard & Poor’s 500- stock index and outdoing its peers (funds that invest in stocks with value and growth characteristics). The fund’s stake in health care stocks Abbott Laboratories, Bio-Techne and UnitedHealth Group provided a boost during the period; shares in industrial firms such as Fastenal and Honeywell International helped, too.

The fund’s Minnesota-based management shifted slightly in April. Mark Henneman and Andrew Adams switched roles. Adams is now lead manager, and Henneman—who became the firm’s chairman and chief executive in January 2018—is now a comanager. “I loved being lead manager of the Growth fund,” says Henneman, “but I realized I couldn’t do both jobs effectively.” Longtime analyst Peter Johnson was also named a comanager.

The trio “row in the same direction,” says Henneman, looking for firms with durable competitive advantages trading at a bargain price. They bought more shares of UnitedHealth when the stock sank recently due to talk about a single-payer health care system.

The fund is lumped with large-company stock funds, but the managers invest in firms of all sizes. More than 30% of assets are devoted to small- and midsize-company stocks, double the typical exposure of its peers. And the managers favor firms that are headquartered in the upper Midwest, on the theory that proximity gives them an edge.

At times, these idiosyncrasies have held the fund back. In 2015, for example, the fund underperformed due to its small- and midsize-company stocks. And Growth has held just 10% of its assets in tech shares historically (such shares tend to be pricey, and there aren’t many tech firms in the Midwest). That’s half the exposure of its typical peer. So in 2017, as tech stocks soared, Growth fell behind. But over the long haul, the fund delivers. Its 15-year 8.7% annualized return matches the S&P 500 and beats 78% of similar funds.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
9 Great Growth ETFs for 2022 and Beyond
ETFs

9 Great Growth ETFs for 2022 and Beyond

These growth ETFs offer exposure to higher-risk, higher-reward stocks while lessening the risk of a single stock torpedoing your returns.
January 18, 2022
The 10 Best Closed-End Funds (CEFs) for 2022
CEFs

The 10 Best Closed-End Funds (CEFs) for 2022

These high-yielding CEFs won't just significantly boost your portfolio income. They'll also allow you to buy their underlying stocks and bonds at a di…
January 12, 2022

Recommended

Semiconductor Stocks: A Smart Bet for the Long Haul
Becoming an Investor

Semiconductor Stocks: A Smart Bet for the Long Haul

Stocks in this growing industry will stay in demand long after supply-chain snarls are unraveled.
January 26, 2022
The Right Dividend Stock Fund for You
Becoming an Investor

The Right Dividend Stock Fund for You

Dividend stock strategies come in many different flavors. Here's what to look for.
January 26, 2022
Primecap Odyssey Growth Has a Rough Year
mutual funds

Primecap Odyssey Growth Has a Rough Year

The fund trailed the S&P by a wide margin, but over the long haul Primecap's managers have not disappointed shareholders.
January 26, 2022
Could the Stock Market Crash for Real? Here’s How to Prepare
investing

Could the Stock Market Crash for Real? Here’s How to Prepare

After a long march to record heights, the stock market tripped into correction territory in January. How should you react? Thoughtfully.
January 25, 2022